(Q36562471)

English

Disease progression model in subjects with mild cognitive impairment from the Alzheimer's disease neuroimaging initiative: CSF biomarkers predict population subtypes

scientific article published on January 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 August 2017

Disease progression model in subjects with mild cognitive impairment from the Alzheimer's disease neuroimaging initiative: CSF biomarkers predict population subtypes (English)

1 reference

Europe PubMed Central

14 August 2017

0 references

Alzheimer's Disease Neuroimaging Initiative

0 references

0 references

Alzheimer's disease

1 reference

based on heuristic

inferred from title

mild cognitive impairment

1 reference

based on heuristic

inferred from title

cognitive dysfunction

1 reference

based on heuristic

inferred from title

Alzheimer's Disease Neuroimaging Initiative

11

object named as

Alzheimer's Disease Neuroimaging Initiative

1 reference

Europe PubMed Central

14 August 2017

author name string

Mahesh N Samtani

1

1 reference

Europe PubMed Central

14 August 2017

Nandini Raghavan

2

1 reference

Europe PubMed Central

14 August 2017

Yingqi Shi

3

1 reference

Europe PubMed Central

14 August 2017

Gerald Novak

4

1 reference

Europe PubMed Central

14 August 2017

Michael Farnum

5

1 reference

Europe PubMed Central

14 August 2017

Victor Lobanov

6

1 reference

Europe PubMed Central

14 August 2017

Tim Schultz

7

1 reference

Europe PubMed Central

14 August 2017

Eric Yang

8

1 reference

Europe PubMed Central

14 August 2017

Allitia DiBernardo

9

1 reference

Europe PubMed Central

14 August 2017

Vaibhav A Narayan

10

1 reference

Europe PubMed Central

14 August 2017

language of work or name

0 references

publication date

1 January 2013

1 reference

Europe PubMed Central

14 August 2017

British Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

14 August 2017

75

1 reference

Europe PubMed Central

14 August 2017

1

1 reference

Europe PubMed Central

14 August 2017

146-161

1 reference

Europe PubMed Central

14 August 2017

Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555054

30 September 2017

Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555054

30 September 2017

Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555054

30 September 2017

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555054

30 September 2017

An improved model for disease progression in patients from the Alzheimer's disease neuroimaging initiative

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555054

30 September 2017

The relative efficiency of time-to-threshold and rate of change in longitudinal data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555054

30 September 2017

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555054

30 September 2017

Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555054

30 September 2017

Assessing the progression of mild cognitive impairment to Alzheimer's disease: current trends and future directions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555054

30 September 2017

APOE and cholesterol homeostasis in Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555054

30 September 2017

Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555054

30 September 2017

Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555054

30 September 2017

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555054

30 September 2017

Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555054

30 September 2017

Mild cognitive impairment: ten years later

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555054

30 September 2017

Population pharmacokinetic analysis of varenicline in adult smokers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555054

30 September 2017

Cerebrospinal fluid biomarkers and rate of cognitive decline in very mild dementia of the Alzheimer type

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555054

30 September 2017

Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555054

30 September 2017

Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555054

30 September 2017

Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555054

30 September 2017

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555054

30 September 2017

Cholesterol in Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555054

30 September 2017

PsN-Toolkit--a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555054

30 September 2017

Membrane dynamics, cholesterol homeostasis, and Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555054

30 September 2017

Mild cognitive impairment clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555054

30 September 2017

Comparison of stepwise covariate model building strategies in population pharmacokinetic-pharmacodynamic analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555054

30 September 2017

Analysis of logistic growth models

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555054

30 September 2017

Modeling the time-course of Alzheimer dementia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555054

30 September 2017

A functional decline model for prevalent cohort data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555054

30 September 2017

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555054

28 June 2018

Modelling mini mental state examination changes in Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555054

28 June 2018

A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555054

28 June 2018

Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2012.04308.X

21 January 2018

Application of a growth curve approach to modeling the progression of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2012.04308.X

21 January 2018

Reliability of estimates of changes in mental status test performance in senile dementia of the Alzheimer type.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2012.04308.X

21 January 2018

Disease progression model for cognitive deterioration from Alzheimer's Disease Neuroimaging Initiative database.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2012.04308.X

21 January 2018

Is Human Height Bimodal?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2012.04308.X

21 January 2018

Hippocampal atrophy in Alzheimer disease: age matters.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2012.04308.X

21 January 2018

Mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2012.04308.X

21 January 2018

Mixture models and subpopulation classification: a pharmacokinetic simulation study and application to metoprolol CYP2D6 phenotype

1 reference

https://pubmed.ncbi.nlm.nih.gov/22534009

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Power, selection bias and predictive performance of the Population Pharmacokinetic Covariate Model

1 reference

https://pubmed.ncbi.nlm.nih.gov/22534009

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2125.2012.04308.X

1 reference

Europe PubMed Central

14 August 2017

1 reference

Europe PubMed Central

14 August 2017

1 reference

Europe PubMed Central

14 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36562471&oldid=2112079920"